Skip to content
Biodatica
Start free

Johnson & Johnson Enterprise Innovation Inc.

Jacksonville, Florida

OncologyPhase IListed · JNJ

This company trades under its own ticker, so it sits outside Biodatica’s pre-ticker window. The record stays here because its filings are real, but the feed leaves listed companies out unless you ask for them.

Compare Sign in to watch

What changed

Phase I trial registered: A Study of JNJ-1761981 in Participants With Solid Tumors

2w agoTrial registeredJul 6, 2026Source filing (opens the source filing in a new tab)

Momentum

93no change

Momentum 93 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase I

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE1 registered

    May 18, 2026

    Neoplasms · RECRUITING · sponsor: Johnson & Johnson Enterprise Innovation Inc. · A Study of JNJ-1761981 in Participants With Solid Tumors

    ClinicalTrials.gov · NCT07525141 (opens the source filing in a new tab)

  2. Trial

    PHASE1 registered

    Jan 26, 2026

    Squamous Cell Carcinoma of Head and Neck · RECRUITING · sponsor: Johnson & Johnson Enterprise Innovation Inc. · A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

    ClinicalTrials.gov · NCT07219212 (opens the source filing in a new tab)

  3. Trial

    PHASE1 registered

    Nov 27, 2023

    Carcinoma, Non-small-Cell Lung · RECRUITING · sponsor: Johnson & Johnson Enterprise Innovation Inc. · A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

    ClinicalTrials.gov · NCT06116786 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources